WALTHAM, Mass., May 10, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 24, 2017 from 8:30 a.m. to 12:00 p.m. Eastern Time. Members of AMAG’s management team and industry experts will provide updates on the Company’s pipeline and commercial programs. In-person attendance requires advanced registration. Please email [email protected] for further information.
A live webcast of the event will be accessible through the Investors section of the company’s website at www.amagpharma.com. A replay of the webcast will also be available and archived on the site.
About AMAG
AMAG is a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our currently marketed products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. Through CBR®, we also help families to preserve newborn stem cells, which are used today in transplant medicine for certain cancers and blood, immune and metabolic disorders, and have the potential to play a valuable role in the ongoing development of regenerative medicine. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. and CBR® is a registered trademark of CBR Systems, Inc.
AMAG Pharmaceuticals Contact: Christi Waarich Associate Director, Investor Relations 617-498-7638


Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 



